28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector — RxCUI 1435115
RxNorm drug concept · Semantic clinical drug
RxCUI 1435115
Semantic clinical drug · SCD
● Current RxNorm concept 10 FDA products
10 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1435115
Official name28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asteriparatide 20 MCG/ACTUAT Pen Injector, 28 ACTUAT; teriparatide 20 MCG/Dose in 28 Dose Pen Injector
FDA products mapped10
Package NDCs mapped10
Reported Medicaid activity (SDUD)12,873 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Teriparatide Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Most osteoporosis drugs work by slowing down the cells that break bone down. Teriparatide works the opposite way — it actually stimulates your body to build new bone. It's a lab-ma...
- What exactly is teriparatide and how is it different from other osteoporosis medications?
- You'll use a prefilled pen device to inject it just under the skin — into your thigh or abdomen — once a day. Your pharmacist or nurse will walk you through the first time. For the...
- How do I give myself the injection and are there things I need to know before I start?
🕸️ Concept Web — How 28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Inject... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector
RxCUI 1435115 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Teriparatide
32915IN
-
Teriparatide
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Bonsity
2716404BN -
Forteo
352657BN
-
Bonsity
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Teriparatide Pen Injector
1659758SCDF -
Teriparatide Injectable Product
1164244SCDG -
Teriparatide Pen Injector [Bonsity]
2716407SBDF -
Teriparatide Pen Injector [Forteo]
1659760SBDF -
Bonsity Injectable Product
2716406SBDG -
Forteo Injectable Product
1172632SBDG -
Pen Injector
1649571DF -
Injectable Product
1151126DFG
-
Teriparatide Pen Injector
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Teriparatide 0.02 MG/ACTUAT
1435114SCDC -
28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector [Bonsity]
2716408SBD -
28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector [Forteo]
1435117SBD -
Teriparatide 0.02 MG/ACTUAT [Bonsity]
2716405SBDC -
Teriparatide 0.02 MG/ACTUAT [Forteo]
1435116SBDC
-
Teriparatide 0.02 MG/ACTUAT
Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Teriparatide 0.02 MG/ACTUAT
SCDC · 1435114 -
Teriparatide Pen Injector
SCDF · 1659758 -
Teriparatide Injectable Product
SCDG · 1164244
Brand-Name Concepts
-
28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector [Bonsity]
SBD · 2716408 -
28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector [Forteo]
SBD · 1435117 -
Teriparatide 0.02 MG/ACTUAT [Bonsity]
SBDC · 2716405 -
Teriparatide 0.02 MG/ACTUAT [Forteo]
SBDC · 1435116 -
Teriparatide Pen Injector [Bonsity]
SBDF · 2716407 -
Teriparatide Pen Injector [Forteo]
SBDF · 1659760 -
Bonsity Injectable Product
SBDG · 2716406 -
Forteo Injectable Product
SBDG · 1172632 -
Bonsity
BN · 2716404 -
Forteo
BN · 352657
📦 FDA Products & Package NDCs
10 products · 10 package NDCs
10 package NDCs map to RxCUI 1435115 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00002-8400-01 | 1 SYRINGE in 1 CARTON (0002-8400-01) / 2.24 mL in 1 SYRINGE | Forteo | Eli Lilly and Company | 2008-10-01 |
| 00002-9678-01 | 1 SYRINGE in 1 CARTON (0002-9678-01) / 2.24 mL in 1 SYRINGE | Forteo | Eli Lilly and Company | 2025-06-03 |
| 00093-1106-16 | 1 SYRINGE in 1 CARTON (0093-1106-16) / 2.24 mL in 1 SYRINGE | Teriparatide | Teva Pharmaceuticals USA, Inc. | 2023-12-18 |
| 00548-2311-00 | 1 SYRINGE in 1 CARTON (0548-2311-00) / 2.24 mL in 1 SYRINGE | Teriparatide | Amphastar Pharmaceuticals, Inc. | 2025-12-22 |
| 47781-0652-89 | 1 SYRINGE in 1 CARTON (47781-652-89) / 2.24 mL in 1 SYRINGE | teriparatide | Alvogen, Inc. | 2019-11-14 |
| 47781-0852-89 | 1 SYRINGE in 1 CARTON (47781-852-89) / 2.24 mL in 1 SYRINGE | Bonsity | Alvogen Inc. | 2025-06-06 |
| 60505-6188-00 | 1 SYRINGE in 1 CARTON (60505-6188-0) / 2.24 mL in 1 SYRINGE | Teriparatide | Apotex Corp. | 2023-11-17 |
| 66993-0495-28 | 1 SYRINGE in 1 CARTON (66993-495-28) / 2.24 mL in 1 SYRINGE | Teriparatide | Prasco Laboratories | 2023-11-17 |
| 66993-0989-28 | 1 SYRINGE in 1 CARTON (66993-989-28) / 2.24 mL in 1 SYRINGE | Teriparatide | Prasco Laboratories | 2025-06-16 |
| 68001-0693-76 | 1 SYRINGE in 1 CARTON (68001-693-76) / 2.24 mL in 1 SYRINGE | Teriparatide | BluePoint Laboratories | 2026-03-19 |
Observed labelers:
Eli Lilly and Company (2) ·
Prasco Laboratories (2) ·
Alvogen Inc. (1) ·
Alvogen, Inc. (1) ·
Amphastar Pharmaceuticals, Inc. (1) ·
Apotex Corp. (1)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.